2022-12-30 Enterprise News
Investors hand Vaxxas $23M to support trial of needle-free COVID-19 vaccine
Vaxxas has raised $23 million to advance needle-free vaccine delivery technology that has caught the attention of groups including the World Health Organization (WHO), and the Bill and Melinda Gates Foundation.
